| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +3.97% | +0.25% | +3.72% | +3.72% | — |
| 14d | 1 | +100.00% | +13.15% | +1.01% | +12.14% | +12.14% | — |
| 30d | 1 | +100.00% | +9.59% | +2.18% | +7.41% | +7.41% | — |
| 60d | 1 | +100.00% | +43.15% | +0.77% | +42.38% | +42.38% | — |
| 90d | 1 | +100.00% | +57.53% | +3.34% | +54.19% | +54.19% | — |
| 180d | 1 | +0.00% | -13.84% | -0.74% | -13.10% | -13.10% | — |
| 1y | 1 | +0.00% | -57.53% | -5.17% | -52.36% | -52.36% | — |
| 2y | 1 | +0.00% | -85.62% | +6.89% | -92.50% | -92.50% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 6,000 | $8.00 | $48.0K | 6,000 | Jul 29, 2021 | Aug 2, 2021 ↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | SALE Chief Business Officer | 10,529 | — | — | 0 | Jul 21, 2020 | Jul 21, 2020 ↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | PURCHASE Chief Business Officer | 10,529 | — | — | 11,254 | Jul 21, 2020 | Jul 21, 2020 ↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | PURCHASEGRANT Stock grant | 22,794 | — | — | 22,794 | Jul 16, 2020 | Jul 17, 2020 ↗ |